Our Bureau
London
Dr Tony Dhillon, a consultant medical oncologist at the Royal Surrey NHS Foundation Trust, proposed the idea for the trial of a vaccine to treat early bowel cancer for patients worldwide. He has worked with Professor Tim Price in Australia for the last 4 years to develop the vaccine. Dr Dhillon, the British-Indian doctor, is the chief investigator of this “ground-breaking” trial.
Dr Dhillon obtained his Bachelor of Science in 1994, qualified in medicine from University College London in 1997 and obtained his PhD in cancer cell signalling from Imperial College London in 2009 funded by a CR-UK clinical training fellowship. He is also Consultant medical oncologist at the Royal Surrey County Hospital since 2014. His main research interests are in liver cancers – primary and metastatic. His particular interests are in resistance mechanisms to anti-cancer treatments and biomarkers.
He has previously been a Wellcome Trust clinical fellow in the University of Oxford looking at gene regulation in varying chromosomal environments and senior lecturer in oncology at Imperial College London working on cell-free DNA in lung cancer. Dr Dhillion is Senior Lecturer in Oncology, the University of Surrey, and Consultant Medical Oncologist, Royal Surrey County Hospital.
Dr Dhillion’s family comes from a village called Surja in Jalandhar. It was his grandfather who relocated to UK. The 53-year-old doctor was born in Maidenhead.
